-
Signature
-
/s/ Tracy Foard, Attorney-in-Fact
-
Stock symbol
-
MQ
-
Transactions as of
-
Dec 1, 2023
-
Transactions value $
-
-$361,008
-
Form type
-
4
-
Date filed
-
12/5/2023, 04:41 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
MQ |
Class A Common Stock |
Options Exercise |
$0 |
+8.85K |
|
$0.00 |
8.85K |
Dec 1, 2023 |
Direct |
F1 |
transaction |
MQ |
Class A Common Stock |
Tax liability |
-$19.5K |
-3.06K |
-34.58% |
$6.37 |
5.79K |
Dec 1, 2023 |
Direct |
F2 |
transaction |
MQ |
Class A Common Stock |
Options Exercise |
$0 |
+39.6K |
+683.8% |
$0.00 |
45.4K |
Dec 1, 2023 |
Direct |
F1 |
transaction |
MQ |
Class A Common Stock |
Tax liability |
-$114K |
-18K |
-39.6% |
$6.37 |
27.4K |
Dec 1, 2023 |
Direct |
F2 |
transaction |
MQ |
Class A Common Stock |
Options Exercise |
$106K |
+26K |
+94.71% |
$4.07 |
53.4K |
Dec 4, 2023 |
Direct |
|
transaction |
MQ |
Class A Common Stock |
Sale |
-$162K |
-26K |
-48.64% |
$6.23 |
27.4K |
Dec 4, 2023 |
Direct |
F3 |
transaction |
MQ |
Class A Common Stock |
Sale |
-$171K |
-27.4K |
-100% |
$6.23 |
0 |
Dec 4, 2023 |
Direct |
F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
MQ |
Restricted Stock Units |
Options Exercise |
$0 |
-8.85K |
-11.11% |
$0.00 |
70.8K |
Dec 1, 2023 |
Class A Common Stock |
8.85K |
|
Direct |
F1, F4, F5 |
transaction |
MQ |
Restricted Stock Units |
Options Exercise |
$0 |
-39.6K |
-10% |
$0.00 |
356K |
Dec 1, 2023 |
Class A Common Stock |
39.6K |
|
Direct |
F1, F4, F6 |
transaction |
MQ |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-26K |
-3.45% |
$0.00 |
727K |
Dec 4, 2023 |
Class A Common Stock |
26K |
$4.07 |
Direct |
F7 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
Chief Product and Technology Officer